# Editorial: Utilization of pharmacogenomics in clinical practice

**Authors:** Apostolos Papachristos, Jessica Cusato, Sujit Nair, Simran Maggo, Vijayaprakash Suppiah

PMC · DOI: 10.3389/fgene.2024.1470698 · Frontiers in Genetics · 2024-08-20

## Full-text entities

- **Genes:** NAT2 (N-acetyltransferase 2) [NCBI Gene 10] {aka AAC2, NAT-2, PNAT}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, COQ3 (coenzyme Q3, methyltransferase) [NCBI Gene 51805] {aka DHHBMT, DHHBMTASE, UG0215E05, bA9819.1}, CYP2C19 (cytochrome P450 family 2 subfamily C member 19) [NCBI Gene 1557] {aka CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19}, COQ5 (coenzyme Q5, methyltransferase) [NCBI Gene 84274] {aka COQ10D9}, COQ2 (coenzyme Q2, polyprenyltransferase) [NCBI Gene 27235] {aka CL640, COQ10D1, MSA1, PHB:PPT}
- **Diseases:** delayed hypersensitivity reactions (MESH:D006967), allergy (MESH:D004342), SJS/TEN (MESH:D010009), bipolar (MESH:D001714), schizoaffective disorder (MESH:D011618), stroke (MESH:D020521), schizophrenia (MESH:D012559), SRM (MESH:D000081030), adverse drug reactions (MESH:D064420), DRESS (MESH:D063926), penicillin (MESH:D008586), mental illness (MESH:D001523), SCARs (MESH:D002921)
- **Chemicals:** Vancomycin (MESH:D014640), PGx (MESH:D011464), flucloxacillin (MESH:D005436), allopurinol (MESH:D000493), ezetimibe (MESH:D000069438), atorvastatin (MESH:D000069059), anti-osteoporotic drugs (-), dapsone (MESH:D003622), Co-trimoxazole (MESH:D015662), CoQ10 (MESH:C024989), Penicillins (MESH:D010406)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs10849757, rs4693075, rs11548336

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11368833/full.md

---
Source: https://tomesphere.com/paper/PMC11368833